Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.
Acute Lymphoblastic Leukemia in a Man Treated With Fingolimod for Relapsing Multiple Sclerosis.
Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
The discovery of natalizumab, a potent therapeutic for multiple sclerosis.
The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies.
Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.
Cell-based therapy approaches: the hope for incurable diseases.
Chronic pain following spinal cord injury.
[Basic mechanisms of action of fingolimod in relation to multiple sclerosis].
Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis (SIMCOMBIN)
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study.
Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial.
Copaiba Oil Suppresses Inflammatory Cytokines in Splenocytes of C57Bl/6 Mice Induced with Experimental Autoimmune Encephalomyelitis (EAE).
Acute disseminated encephalomyelitis in Siriraj Hospital: clinical manifestations and short-term outcome.
The grey matter correlates of impaired decision-making in multiple sclerosis.
Neuroscience. To learn is to myelinate.
Regulation of ceramide synthase 6 in a spontaneous experimental autoimmune encephalomyelitis model is sex dependent.
Transgenic inhibition of astroglial NF-kappaB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.
JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
[Clinical significance of T-regulatory cells in multiple sclerosis.]
Minocycline Hydrochloride (1818)
The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a new class of nanomolar FKBP12 ligands.
Chronic social stress impairs virus specific adaptive immunity during acute Theiler's virus infection.

Pages